Skip to content
Open access

Identification of a SARS-CoV-2 Spike RNA-Cleaving DNAzyme and Optimization of Its AS1411 Chimera

Sep 2026 · bioRxiv · 0 citations · 34 references
Biology

TL;DR

Findings identify 8-17-769 as a lead Spike RNA-cleaving deoxyribozyme and demonstrate that the linear organization of aptamer and catalytic modules can substantially influence the structural and functional properties of aptamer–deoxyribozyme chimeras.

Read PDF

Similar papers

Open access Sep 2026

The nucleoside analog CMX521 inhibits coronavirus RNA-dependent RNA polymerase via a two-pronged mechanism

These findings establish a two-pronged mode of coronavirus polymerase inhibition by CMX521, and suggest a second inhibitory mechanism for CMX521 when the coronavirus polymerase is associated with the viral helicase.

Asif Rakib, Calvin J. Gordon, Thomas K. Anderson et al. · 0 citations
Open access Aug 2026

Identification of a Conserved Linear Epitope in SARS-CoV-2 Nucleocapsid Protein Recognized by Monoclonal Antibody N179

This motif may serve as a reference for the selection and evaluation of diagnostic antibodies targeting conserved regions of the SARS-CoV-2 N protein and show that this sequence is conserved among the representative SARS-CoV-2 lineages analyzed.

Zhoujun Su, Junhao Guo, Ning Li et al. · 0 citations
Open access Aug 2026

Structure-guided engineering of an aptamer–PROTAC for targeted degradation of vaccinia-related kinase 1

Vaccinia-related kinase 1 (VRK1) is an oncogenic serine/threonine kinase implicated in tumor progression, yet it remains an intractable target for catalytic degradation. Herein, we report the structure-guided design of a first aptamer–PROTAC chimera for potent and selective degradation of VRK1. Through structure-guided...

Yangfang Yun, Ya-Qing Gao, Yang Shi et al. · 1 citation
Open access Aug 2026

Nanobodies against the S2 region of the spike protein potently neutralize SARS-CoV-2 viruses and show resistance to viral immune escape

The results show the value of nanobody technology for identifying novel neutralising epitopes in the S2 region of beta-coronaviruses with potential for the development of new selective anti-viral agents.

John D. Clarke, Luke M. Jones, Imogen I. H. Buckle et al. · 0 citations

PROTEASE AND ITS MODULATION BY SMALL MOLECULES”

Findings establish that both catalytic and allosteric sites play essential roles in regulating 3CL pro function, and targeting allosteric regions such as the Asn28-associated pocket offers a promising approach for antiviral development.

Unknown authors · 0 citations
Open access Sep 2026

Mutational screening reveals a cluster of residues within the SARS-CoV-2 nsp1 N-terminus that confers RNA-targeting selectivity

The SARS-CoV-2 nsp1 protein is a virulence factor that broadly inhibits cellular gene expression. Although cellular mRNAs are translationally inhibited by nsp1 and subsequently degraded, viral transcripts possess a 5′ leader sequence (CoV2L) that enables them to escape nsp1-mediated repression. Both transcript targetin...

Jaresley V. Guillen, Sherzod A. Tokamov, B. Glaunsinger · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.